Metraipolis › archive › dc_2cccc01d63e9

Sonocrystallization approach in crystal habit modification for improving the pharmaceutical properties of Rivaroxaban — Europe PMC PMID:42276017

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42276017
DOI
10.1016/j.ultsonch.2026.107921
License (as archived)
solo-consultazione
Archived
2026-10-31T16:03:38.351Z
SHA-256 of the archived text
e595328b574cba70bd446a9d12874cf3d06add7ddfb43b4300bbd8269af5ec82
Stable URL of this page
https://metraipolis.com/documento/dc_2cccc01d63e9

How to cite

Sonocrystallization approach in crystal habit modification for improving the pharmaceutical properties of Rivaroxaban — Europe PMC PMID:42276017 — Europe PMC (en), https://europepmc.org/article/MED/42276017 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2cccc01d63e9 (Metraipolis archive dc_2cccc01d63e9, sha256 e595328b574cba70bd446a9d12874cf3d06add7ddfb43b4300bbd8269af5ec82)
BibTeX
@misc{dc2cccc01d63e9,
  title = {Sonocrystallization approach in crystal habit modification for improving the pharmaceutical properties of Rivaroxaban — Europe PMC PMID:42276017},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42276017},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2cccc01d63e9; sha256 e595328b574cba70bd446a9d12874cf3d06add7ddfb43b4300bbd8269af5ec82},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42276017. Agents can read the archived copy with the MCP tool read_document.